Trogarzo (ibalizumab-uiyk)Won FDA Approval For Treating HIV Infections

U.S. FDA(Food and Drug Administration) extends its approval for Trogarzo (ibalizumab-uiyk) used in the treatment of HIV infections.

Brand Name: Trogarzo

Generic Name: ibalizumab-uiyk

Treatment for: HIV Infection

General information about  Trogarzo

Trogarzo (ibalizumab-uiyk) is a humanized monoclonal antibody for the treatment of multidrug resistant human immunodeficiency virus-1 (HIV-1) infection.

Ibalizumab-uiyk is a CD4 domain 2-directed humanized monoclonal antibody of immunoglobulin G (IgG) isotype 4 with a molecular weight of approximately 150 kDa. Ibalizumab-uiyk is produced by recombinant DNA technology in murine myeloma non-secreting 0 (NS0) cells.